Abstract

Background and aimsAutoantibodies targeting Ro52 occur in systemic lupus erythematosus, Sjogren’s syndrome and idiopathic inflammatory myopathies. Yet the most compelling evidence for their pathogenesis is the development of cardiac conduction...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call